Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-26
2006-12-26
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S016700, C514S017400
Reexamination Certificate
active
07153833
ABSTRACT:
A method for treating or reducing the severity of a disease or disorder mediated by a membrane metallopeptidase by administering to a mammal a SMR1-peptide or a pharmaceutically active amount of a SMR1-peptide.
REFERENCES:
patent: 5302582 (1994-04-01), Vertesy et al.
patent: 5550119 (1996-08-01), De Lombaert et al.
patent: 5859189 (1999-01-01), Rosinski-Chupin et al.
patent: 6025143 (2000-02-01), Rosinski-Chupin et al.
patent: 6589750 (2003-07-01), Rougeot et al.
patent: 6818405 (2004-11-01), Rougeot et al.
patent: 2003/0078200 (2003-04-01), Marcel et al.
patent: 2003/0170620 (2003-09-01), Rosinski-Chupin et al.
patent: 2003/0186870 (2003-10-01), Marcel et al.
patent: 2003/0195155 (2003-10-01), Rougeot et al.
patent: 2980334 (1999-11-01), None
patent: 90 03981 (1990-04-01), None
patent: WO 90/03981 (1990-04-01), None
patent: 98 37100 (1998-08-01), None
Catherine Rougeot et al.: “Rodent submandibular gland peptide hormones and other biologically active peptides” PEPTIDES, vol. 21, No. 3, pp. 443-455, 2000.
Rougeon François
Rougeot Catherine
Centre National de la Recherche Scientifique (C.N.R.S.)
Institut Pasteur
Russel Jeffrey Edwin
LandOfFree
Therapeutic uses of SMR1 peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of SMR1 peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of SMR1 peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3719842